librico Company Asbestos Trust Fund Claims
The formal trust is the Plibrico 524(g) Asbestos Trust, commonly called the Plibrico Asbestos Trust. It was established on March 8, 2006 following the Chapter 11 reorganization of Plibrico Company and Plibrico Sales and Service, Inc. The Trust resolves qualifying asbestos personal-injury claims arising from exposure to asbestos-containing products sold by the Plibrico entities or their predecessors. The Trust remains active and currently applies a 0.94% Payment Percentage.
Plibrico Asbestos Trust Facts
| Formal trust name | Plibrico 524(g) Asbestos Trust |
|---|---|
| Debtors | Plibrico Company and Plibrico Sales and Service, Inc. |
| Chapter 11 petition date | March 13, 2002 |
| Trust established | March 8, 2006 |
| Current TDP | Third Amended and Restated Asbestos Trust Distribution Procedures, amended and restated as of October 1, 2024 |
| Trustee | Marc E. Wolin |
| Claims administration | Verus Claims Services |
| Current Payment Percentage | 0.94% |
| 0.94% effective date | October 1, 2024 |
| Prior Payment Percentage | 1.21% |
| Mesothelioma values | $350,000 Scheduled / $425,000 Average / $750,000 Maximum |
| Claim filing fee | $52 per claim filed on or after October 1, 2024; refundable if the claim is determined compensable |
| Current status | Active |
Bankruptcy and Trust History
The official Trust states that the Plibrico Asbestos Trust was established on March 8, 2006 as a result of the Chapter 11 reorganization of Plibrico Company and Plibrico Sales and Service, Inc.
The current TDP identifies March 13, 2002 as the Petition Date. The TDP covers asbestos-related personal-injury and death claims caused in whole or in part by exposure to asbestos-containing products sold by the Plibrico entities or their predecessors for which those entities have legal liability.
The Trust is designed to process and pay qualifying claims generally on an impartial first-in, first-out basis while attempting to treat present and future claimants as equivalently as possible.
Disease Values and Claim Review
The October 1, 2024 Third Amended and Restated TDP publishes the following Scheduled, Average and Maximum Values:
| Disease Level | Scheduled Value | Average Value | Maximum Value |
|---|---|---|---|
| Mesothelioma — Level VII | $350,000 | $425,000 | $750,000 |
| Lung Cancer 1 — Level VI | $120,000 | $135,000 | $200,000 |
| Lung Cancer 2 — Level V | None | $45,000 | $135,000 |
| Other Cancer — Level IV | $65,000 | $70,000 | $100,000 |
| Severe Asbestosis — Level III | $120,000 | $135,000 | $200,000 |
| Asbestosis/Pleural Disease — Level II | $15,000 | Not separately stated | $15,000 |
| Other Asbestos Disease — Level I | $1,500 | Not separately stated | $1,500 |
These are liquidated-value benchmarks, not guaranteed payments. Expedited Review is available for Disease Levels I–IV and VI–VII when the applicable medical and exposure criteria are met. Lung Cancer 2 claims must be handled through Individual Review.
Need help now? Call 800.291.0963
Live chat available 24/7, 365 days a year.
Submit Your Case
Current 0.94% Payment Percentage
An official Trust notice dated August 27, 2024 reduced the Payment Percentage from 1.21% to 0.94%, effective October 1, 2024. The Trustee states that the adjustment was made with the consent of the Trust Advisory Committee and Futures Representative.
The notice also states that claimants receive payment on the gross liquidated value of their claims at the Payment Percentage in effect at the time of payment.
Mathematical illustration only — not a guaranteed payment. $350,000 Mesothelioma Scheduled Value × 0.94% = $3,290. The $425,000 Average Value × 0.94% = $3,995. The $750,000 Maximum Value × 0.94% = $7,050. A claimant is not guaranteed the Scheduled, Average or Maximum Value.
2024 Claim-Processing Changes
The Trust adopted additional claim-processing changes effective October 1, 2024. Processing of a claim that would not result in a payment of at least $100 is suspended until the Payment Percentage rises enough to produce a payment of at least $100.
The same official notice states that the statute of limitations for a suspended claim is tolled while that suspension applies, subject to the timing rules stated in the amended TDP and notice.
At the current 0.94% Payment Percentage, the published $1,500 Level I value would mathematically produce $14.10, so a claim liquidated at that value falls below the $100 processing threshold. By contrast, $15,000 × 0.94% = $141 before any other applicable adjustments.
The October 2024 amendments also set the sequencing-adjustment factor at 2.5% and cap the annual CPI-U adjustment to claim values at 2.5%, each subject to periodic review under the TDP.
Medical and Exposure Requirements
The current TDP requires disease-specific medical proof and qualifying Plibrico Exposure.
Mesothelioma Level VII requires a qualifying mesothelioma diagnosis and Plibrico Exposure. Lung Cancer 1 requires primary lung cancer, evidence of an underlying bilateral asbestos-related nonmalignant disease, six months of Plibrico Exposure, Significant Occupational Exposure and medical documentation establishing asbestos exposure as a contributing factor.
Other Cancer and Severe Asbestosis also require six months of Plibrico Exposure, Significant Occupational Exposure and disease-specific medical evidence. Level II requires qualifying asbestosis or bilateral pleural disease, pulmonary-function impairment, six months of Plibrico Exposure and Significant Occupational Exposure.
Exposure evidence can include credible proof connecting the claimant to asbestos-containing products sold by Plibrico Company, Plibrico Sales and Service, Inc. or covered predecessors.
Claim Filing and $52 Fee
Effective October 1, 2024, the Trust requires a $52 filing fee for each claim. The Trust will not process the claim or place it in the FIFO Processing Queue until the filing fee is paid.
If the fee is not received within 30 days after the Trust receives the claim, the claim is not classified as filed, the statute of limitations is not tolled, and the claim is withdrawn from Verus’s Claims Management System.
If the claim is determined to be compensable, the $52 filing fee is refunded in full when the claim is paid. Otherwise, the fee is non-refundable.
A claim also must be sufficiently complete to be reviewed, including a properly completed Claim Form or electronic filing and the required supporting medical and exposure documentation.
FIFO, Individual Review and Special Claims
Plibrico claims are generally processed according to a FIFO Processing Queue. Qualifying Disease Levels can use Expedited Review, while Individual Review is available in circumstances specified by the TDP.
Lung Cancer 2 claims are handled only through Individual Review. Claims in Disease Levels III–VII may also seek Individual Review when a claimant wants the Trust to evaluate a liquidated value above the Scheduled Value. Individual Review can result in a value below the Scheduled Value and ordinarily cannot exceed the applicable Maximum Value.
The TDP defines Extraordinary Claims to include qualifying claims where at least 75% of the claimant’s asbestos exposure resulted from a specific asbestos-containing product manufactured or distributed by the Plibrico entities or predecessors and there is little likelihood of substantial recovery elsewhere. Such claims undergo Individual Review and remain subject to the Payment Percentage and other Trust limitations.
The Trust’s public Notices page reviewed for this build contains an annual report for fiscal year 2013 but does not provide a sufficiently current audited 2025 or 2026 report establishing present total assets, cumulative claims paid or lifetime dollars paid. Those figures are therefore omitted rather than estimated or copied from law-firm or lead-generation websites.
Confirmed Primary Sources for Trust Facts
No law-firm or lead-generation website was used as factual authority for this page. Primary Trust materials reviewed include:
- Official Plibrico Asbestos Trust website.
- Official Trust Notices page.
- Official Third Amended and Restated Asbestos Trust Distribution Procedures, October 1, 2024.
- Official August 27, 2024 Payment Percentage notice reducing the rate to 0.94%.
- Official $52 claim-filing-fee notice.
- Official summary of October 1, 2024 claims-processing changes.
Related Asbestos Trust Fund Resources
Asbestos Trust Fund Information
Filing and Eligibility
Payments and Trust Rules
- Official 0.94% Payment Percentage notice
- Official claim-processing changes
- Official Trust Distribution Procedures
Frequently Asked Questions About the Plibrico Asbestos Trust
What is the formal Plibrico asbestos trust name?
The formal name is the Plibrico 524(g) Asbestos Trust.
Is the Plibrico Asbestos Trust active?
Yes. The official Trust website continues to provide active claim materials, amended procedures and current notices.
What is the current Plibrico Payment Percentage?
The current officially published Payment Percentage is 0.94%, effective October 1, 2024, reduced from 1.21%.
What is the Plibrico mesothelioma value?
The current TDP lists $350,000 Scheduled, $425,000 Average and $750,000 Maximum for Mesothelioma Level VII.
What does 0.94% of the mesothelioma Scheduled Value equal?
$350,000 multiplied by 0.94% equals $3,290. This is a mathematical illustration only — not a guaranteed payment.
Which claims are currently suspended because of the $100 threshold?
The Trust suspends processing of any claim that would result in a payment below $100 until the Payment Percentage increases enough to produce at least $100, subject to the amended rules.
Does Plibrico charge a filing fee?
Yes. Claims filed on or after October 1, 2024 require a $52 filing fee. It is refunded if the claim is determined compensable and paid.
Does Plibrico offer Individual Review?
Yes. Individual Review is available under the TDP, and Lung Cancer 2 claims must be processed through Individual Review.
Get Help Reviewing a Plibrico Asbestos Trust Claim
Call 800.291.0963
Live chat is available 24/7, 365 days a year.
Prior work around refractory or high-temperature materials does not automatically establish Plibrico exposure, Trust eligibility or compensation. Eligibility depends on diagnosis, qualifying product exposure evidence, medical documentation, current Trust procedures, filing requirements and individual circumstances. Compensation is not guaranteed.
⚕️ Legal & Medical Information Disclaimer
This page provides general educational information and is not medical or legal advice. The information does not establish asbestos exposure, diagnosis, causation, liability, claim eligibility or compensation. Medical concerns should be discussed with a qualified healthcare professional, and legal questions should be reviewed with a qualified attorney.